ABout Us
KosmodeHealth expands access to health from nature as a business enabler. We resolve issues of high extraction cost limiting mass market access to quality plant extracts and high wastage of agri/food by- products in food industry; and issues of animal protein bio material and limited availability of bioscaffold for 3D cell culture in biomedical industry.
One Company, impacting Two Industries, with Three Technologies
OUR FOUNDERS
Florence Leong is an ex-pharmaceutical executive turned startup enthusiast . Building on her decades of organizational and market development experience in top pharmaceutical multinationals, venture capital investment and management practice, she contributes to the Singapore startup ecosystem as an Advisor, Mentor, Instructor, Founder & Angel Investor. Florence is currently an Industry Advisor in the Singapore Biodesign Program, a mentor in NUS Enterprise and Medtech Track Instructor in the LeanLaunchPad Program.
Dr Huang Dejian,Associate Professor and Deputy Head of Dept of Food Science Technology in the National University of Singapore, is a Chemist and Food Scientist. His research work received global recognisation when he was cited by Thomson Reuter as one of the most cited Agri-scientist for two consecutive years in 2014 & 2015. He is also an Associate Editor in the Journal of Food and a recipient of the Suzhou Industrial Park Talent Program.
Driven by a common passion to expand access to health from nature, Dejian and Florence combined their complementary science and commercial expertise, to resolve challenges in their respective industry of interest – Food for Dejian, and Biomedical for Florence. Resolving 4 Issues in 2 Industries
Driven by strong consumer demand, the large multi-billion plant extract is enjoying a strong double digit CAGR. Unfortunately, due to the lack of regulatory control, this market is dominated by low cost products with questionable quality. Authentic quality ingredients are expensive and beyond the affordability of the mass market. The high cost of quality plant extracts can be attributed to the high cost of current technology – an archaic, batch by batch extraction method. It is an energy intensive extraction method which involves repeated distillation to produce extracts of high purity. The high cost is compounded by the minute amount of bioactive in plants. The amount is often less than 0.1%.
CLICK HERE: Better, Sustainable, Halal Certifiable Plant Extraction Technology.
The industries responsible for producing food to feed mankind is also responsible for generating multi-million tons of by-products per year. These by-products, ‘packed’ with proteins & fibres, are currently dried up at extensive energy cost as fertilizers and animal feed. It is high time these by-products are up-value for human nutrition.
CLICK HERE: Better, Sustainable, Halal Certifiable Plant Extraction Technology.
3D cell culture, which involves the growth of cells outside its natural environment, is a fast growth market for biomedical development. Bioscaffold and 3D bioprinting, are both dominant and growing platforms to facilitate the growth of cells. Animal protein, being a natural protein conducive for cell growth, is currently the preferred biomaterial for scaffold and bio-ink for 3D bioprinting. It is however extremely expensive, lacks reproducibility and printability.
CLICK HERE: Plant Protein Composite (PPC™) Bio-ink Formulation Technology.
Though standard off the shelf scaffolds are available, most of these scaffolds consist of synthetic material which are less conducive for cell growth. As different cells need different micro-environment to be recreated for optimal growth, the range of available scaffolds are too limited to meet the varied growth needs of millions of cells.
CLICK HERE: Controllable and Precise 3D Scaffold Printing Methodology.